Skip to content
★ Sign in to follow
XI

Xtent Inc Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Bellas Robert C JR, was filed 07 Feb 2007.

Xtent Inc: what insiders have been doing

This page follows insider dealings at Xtent Inc as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for Xtent Inc. The previous disclosure was published on 1 October 2008.

The full history, which starts in 2007, counts 2 purchases against 192 sales.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
240
Thresholds
n/a
Buy Volume
€332,718
2 ops. · all time
Sell Volume
€399,555
192 ops. · all time
Last declaration on 1 October 2008
Declarations240 total
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    369 USD0SEC
    300 shares@ US$1.23Common StockSEC:0001212235-08-000113:0
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    125 USD0SEC
    100 shares@ US$1.25Common StockSEC:0001212235-08-000113:1
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    1,040 USD0SEC
    800 shares@ US$1.30Common StockSEC:0001212235-08-000113:2
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    131 USD0SEC
    100 shares@ US$1.31Common StockSEC:0001212235-08-000113:3
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    396 USD0SEC
    300 shares@ US$1.32Common StockSEC:0001212235-08-000113:4
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    266 USD0SEC
    200 shares@ US$1.33Common StockSEC:0001212235-08-000113:5
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    670 USD0SEC
    500 shares@ US$1.34Common StockSEC:0001212235-08-000113:6
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    1,890 USD0SEC
    1,400 shares@ US$1.35Common StockSEC:0001212235-08-000113:7
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    136 USD0SEC
    100 shares@ US$1.36Common StockSEC:0001212235-08-000113:8
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    414 USD0SEC
    300 shares@ US$1.38Common StockSEC:0001212235-08-000113:9
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    417 USD0SEC
    300 shares@ US$1.39Common StockSEC:0001212235-08-000113:10
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    700 USD0SEC
    500 shares@ US$1.40Common StockSEC:0001212235-08-000113:11
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    141 USD0SEC
    100 shares@ US$1.41Common StockSEC:0001212235-08-000113:12
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    99 USD0SEC
    50 shares@ US$1.97Common StockSEC:0001212235-08-000112:0
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    8,800 USD0SEC
    4,400 shares@ US$2.00Common StockSEC:0001212235-08-000112:1
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    704 USD0SEC
    350 shares@ US$2.01Common StockSEC:0001212235-08-000112:2
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    205 USD0SEC
    100 shares@ US$2.05Common StockSEC:0001212235-08-000112:3
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    207 USD0SEC
    100 shares@ US$2.07Common StockSEC:0001212235-08-000112:4
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    253 USD0SEC
    100 shares@ US$2.53Common StockSEC:0001212235-08-000098:0
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    5,610 USD0SEC
    2,200 shares@ US$2.55Common StockSEC:0001212235-08-000098:1
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    256 USD0SEC
    100 shares@ US$2.56Common StockSEC:0001212235-08-000098:2
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    257 USD0SEC
    100 shares@ US$2.57Common StockSEC:0001212235-08-000098:3
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutives
    2,600 USD0SEC
    1,000 shares@ US$2.60Common StockSEC:0001212235-08-000098:4
  • ◇
    Executives
    4 USD0SEC
    10 shares@ US$0.40Common StockSEC:0001212235-08-000096:0
  • ◇
    Executives
    280 USD0SEC
    700 shares@ US$0.40Common StockSEC:0001212235-08-000096:1

25 of 240 declarations

About Xtent Inc

Xtent Inc is a company listed on the XNYS market. It specializes in the development of innovative medical technologies.